Guidance on Preoperative Management of Hand Surgery Patients Taking GLP-1 Receptor Agonists.

IF 1.8 Q2 ORTHOPEDICS

HAND Pub Date : 2024-12-11 DOI:10.1177/15589447241300712

Sara C Kisiel, Annika Hiredesai, Pooja Dhupati, Shelley Noland

引用次数: 0

Abstract

Glucagon-like peptide-1 (GLP-1) receptor agonists are medications used to treat type 2 diabetes and may aid in weight loss efforts. The surgical management of patients taking GLP-1 agonists differs from others due to the slowed gastric emptying effects of GLP-1 medications. Patients taking these medications may have a higher risk of pulmonary aspiration during hand surgery than other patients, which affects their presurgical management. This article reviews GLP-1 agonists and their role in diabetes and weight loss, as well as current recommendations for surgical management of patients taking GLP-1 agonists.

查看原文本刊更多论文

手部手术患者使用GLP-1受体激动剂的术前管理指南。

胰高血糖素样肽-1 （GLP-1）受体激动剂是用于治疗2型糖尿病的药物，可能有助于减肥。由于GLP-1药物的胃排空作用减慢，服用GLP-1激动剂的患者的手术处理与其他患者不同。在手手术中服用这些药物的患者可能比其他患者有更高的肺误吸风险，这影响了他们的术前处理。本文综述了GLP-1激动剂及其在糖尿病和减肥中的作用，以及目前对服用GLP-1激动剂患者的手术治疗的建议。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

HAND Medicine-Surgery

CiteScore

3.30

自引率

0.00%

发文量

209

期刊介绍： HAND is the official journal of the American Association for Hand Surgery and is a peer-reviewed journal featuring articles written by clinicians worldwide presenting current research and clinical work in the field of hand surgery. It features articles related to all aspects of hand and upper extremity surgery and the post operative care and rehabilitation of the hand.